Drugmaker Ignored More Than 200 Bad Quality Tests, FDA Says
U.S. regulators warned Fresenius SE after the company’s Indian plant that makes cancer-drug ingredients for the U.S. market aborted hundreds of drug-quality tests because they seemed like they were going ...